The SURMOUNT-4 randomized clinical trial assessed the effect of tirzepatide discontinuation on the maintenance of weight reduction in adults with obesity and a weight-related complication, excluding diabetes
By targeting the psychological, emotional, and behavioral factors that contribute to weight gain, we empower you to adopt healthier habits and experience lasting aesthetic and health improvements
k , Schematic of cystine stable-isotope labeling approach for metabolomics and proteomics
The MHRA's product information for Mounjaro emphasises the importance of gradual dose titration to minimise these gastrointestinal side effects
Retrieved February 13, 2019
In the double-blind, placebo-controlled ATTAIN-1 trial, continuous use of the highest dose of Foundayo led to an average weight loss of 12.4% (27.3 pounds) after 72 weeks, compared with 0.9% (2.2 pounds) with placebo